Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Lexaria Bioscience Corp
LEXX
Alternate Symbol(s):
LEXXW
Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the...
bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LEXX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on May 30, 2024 5:01am
Buzz on the Bullboards: Volatility persists in the face of economic indicators
Canada’s main stock index struggled and the NASDAQ hit a high, demonstrating a continued appetite for tech stocks amidst market volatility.
read article.
(100)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 28, 2024 1:45pm
Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosi
Just In: $LEXX Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study; Maintains Study Pace and Rollout for 2024Lexaria, a global innovator in drug
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 23, 2024 9:05am
New Press Release - Lexaria Awards Contract For Third GLP-1 Human Pilot Study
(TheNewswire)First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKelowna, British Columbia – May 23, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 21, 2024 9:20am
New Press Release - Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy
(TheNewswire)Kelowna, British Columbia – TheNewswire - May 21, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces two important new patent awards.The Company has received a new granted patent in Lexaria’s...
read article.
(1)
•••
Yowza123
X
View Profile
View Bullboard History
Post by
Yowza123
on May 17, 2024 10:57am
Comprehensive GLP-1 Animal Study Begins Dosing
https://ir.lexariabioscience.com/news-events/press-releases/detail/250/dosing-begins-in-lexarias-comprehensive-glp-1-animal-study
(35)
•••
shawk
X
View Profile
View Bullboard History
Post by
shawk
on May 10, 2024 2:15pm
May Presentation
PowerPoint Presentation (d1io3yog0oux5.cloudfront.net)
(1)
•••
Yowza123
X
View Profile
View Bullboard History
Post by
Yowza123
on May 08, 2024 10:28am
Lexaria update on GLP-1 Human Pilot Study
https://ir.lexariabioscience.com/news-events/press-releases/detail/249/lexaria-begins-dosing-of-its-second-glp-1-human-pilot-study
(100)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 06, 2024 5:00pm
InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ:
NEWS: $LEXX InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 DrugsLexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global
...more
(100)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 30, 2024 3:45pm
Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Ex
Breaking News: $LEXX Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and IssuanceKELOWNA, BC / ACCESSWIRE / April 30, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW
...more
(179)
•••
ranman
X
View Profile
View Bullboard History
Post by
ranman
on Apr 08, 2024 2:15pm
LD Micro Invitational XIV 2024
I'm interested to see if tomorrow's presentation motivates people to buy a few Lexaria Lexaria presents tomorrow at 10:30 am https://ldinv14.sequireevents.com/ Gatekeeper presents tomorrw at
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 02, 2024 9:00am
New Press Release - Lexaria Awarded New Patents
(TheNewswire)Lexaria receives new patents in the fields of epilepsy and anti-viral agentsKelowna, British Columbia – April 2, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces three recent...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 21, 2024 9:21am
New Press Release - Lexaria to Present at The LD Micro Invitational XIV
Kelowna, British Columbia--(Newsfile Corp. - March 21, 2024) - Lexaria Bioscience Corp. (NASDAQ: LEXX) (NASDAQ: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it will be presenting at the 14th Annual LD Micro Invitational at the Sofitel New York...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 14, 2024 9:21am
New Press Release - Lexaria Appoints Nelson Cabatuan as Chief Financial Officer
(TheNewswire)Kelowna, British Columbia / TheNewswire / March 14, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective...
read article.
(1972)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Mar 11, 2024 3:31pm
Some warrants exercised?
Probably $0.95 May 2023 warrants => another $482,210 US cash inflow Shs o/s Nov 30 10,311,641 Feb issue 1
...more
(35)
•••
shawk
X
View Profile
View Bullboard History
Post by
shawk
on Mar 11, 2024 2:45pm
Special Report: Lexaria has a week for the record books
449582_b11b869ac5744f18a682429ffbf12660.pdf (letstoke.biz)
(7)
•••
Star1920
X
View Profile
View Bullboard History
Post by
Star1920
on Mar 08, 2024 9:43am
Valuation
price target $12.00 | 113.14% Average based on 1 ranked analysts Last 12 MonthsNext 12 Months Mar2023Mar20242814Mar2025 Low Estimate
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nanalysis Scientific Corp. Announces First Quarter 2024 Results
This Small-Cap Gold Stock Jumped Almost 50% on Friday